Evidence map›Paper›PMID 26112050›Full record

Trial reportTrials2015

Improving care after colon cancer treatment in The Netherlands, personalised care to enhance quality of life (I CARE study): study protocol for a randomised controlled trial.

Laura A M Duineveld, Thijs Wieldraaijer, Kristel M van Asselt, Ineke C Nugteren, Sandra C Donkervoort, Anthony W H van de Ven, Anke B Smits, Anna A W van Geloven, Willem A Bemelman, Frederique H Beverdam and 7 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Increased survival means increasing roles for primary care after cancer diagnosis.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Laura A M DuineveldAcademic Medical Centre, Department of Primary Care, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. l.a.duineveld@amc.uva.nl.
Thijs WieldraaijerAcademic Medical Centre, Department of Primary Care, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. t.wieldraaijer@amc.uva.nl.
Kristel M van AsseltAcademic Medical Centre, Department of Primary Care, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. k.m.vanaselt@amc.uva.nl.
Ineke C NugterenAcademic Medical Centre, Department of Primary Care, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. i.c.nugteren@amc.uva.nl.
Sandra C DonkervoortDepartment of Surgery, OLVG, Oosterpark 9, 1091, , AC, Amsterdam, The Netherlands. donkpas@online.nl.
Anthony W H van de VenDepartment of Surgery, Flevoziekenhuis, Hospitaalweg 1, 1315, , RA, Almere, The Netherlands. avandeven@flevoziekenhuis.nl.
Anke B SmitsDepartment of Surgery, St. Antonius Hospital, Koekoekslaan 1, 3435, , CM, Nieuwegein, The Netherlands. a.smits@antoniusziekenhuis.nl.
Anna A W van GelovenDepartment of Surgery, Tergooi Hospital, Van Riebeeckweg 212, 1213, , XZ, Hilversum, The Netherlands. avangeloven@tergooi.nl.
Willem A BemelmanDepartment of Surgery, Academic Medical Centre, Meibergdreef 9, 1105, , AZ, Amsterdam, The Netherlands. w.a.bemelman@amc.uva.nl.
Frederique H BeverdamDepartment of Surgery, Vlietland Hospital, Vlietlandplein 2, 3118, , JH, Schiedam, The Netherlands. fbeverdam@sfvg.nl.
Willem F van TetsDepartment of Surgery, St Lucas Andreas Hospital, Jan Tooropstraat 164, 1061, , AE, Amsterdam, The Netherlands. w.vantets@slaz.nl.
Marc J P M GovaertDepartment of Surgery, Westfriesgasthuis, Maelsonstraat 3, 1624, , NP, Hoorn, The Netherlands. m.j.p.m.govaert@westfriesgasthuis.nl.
Judith E BosmansVU University Medical Centre, Department of Health Sciences and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085-1087, 1081, , HV, Amsterdam, The Netherlands. j.e.bosmans@vu.nl.
Irma M Verdonck-de LeeuwDepartment of Clinical Psychology, VU University, van der Boechorststraat 1, 1081, , BT, Amsterdam, The Netherlands. im.verdonck@vumc.nl.
Cornelia F van Uden-KraanDepartment of Clinical Psychology, VU University, van der Boechorststraat 1, 1081, , BT, Amsterdam, The Netherlands. c.vanuden@vumc.nl.
Henk C P M van WeertAcademic Medical Centre, Department of Primary Care, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. h.c.vanweert@amc.uva.nl.
Jan WindAcademic Medical Centre, Department of Primary Care, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. j.wind@amc.uva.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is expected that in 2020 more than 17,000 cases of colorectal cancer will be diagnosed in The Netherlands. To date, patients are included in a surgeon-led follow-up programme whose main focus is recurrence detection. However, patients often experience multiple physical and psychosocial problems. Currently, these problems are not always encountered. More care by a generalist is suggested as a solution. Furthermore, patients prefer to undergo rehabilitation in their own environment and to be more involved in their own health care. eHealth applications might enhance this. Oncokompas(2.0) is an online self-management application which facilitates access to supportive care. This study aims to evaluate primary care follow-up and aftercare in comparison with secondary care follow-up and aftercare for patients with colon cancer. Second, the added value of Oncokompas(2.0) to care will be assessed. METHODS/

designThis is a multi-centre 2 × 2 factorial randomised controlled trial with a calculated sample size of 300 patients. Patients with stage I, II, or III colon carcinoma are eligible. Patients will be randomly assigned in four groups: (1) usual follow-up visits and aftercare provided in secondary care, (2) usual follow-up visits and aftercare provided in secondary care with additional use of Oncokompas(2.0), (3) follow-up and aftercare in primary care, and (4) follow-up and aftercare in primary care with additional use of Oncokompas(2.0). The primary outcome is quality of life. Secondary outcomes include physical outcomes, psychosocial outcomes, number of investigations, referrals and related communication between secondary and primary care, (time of) recurrence detection and protocol adherence, attention to preventive care, self-management of patients, patient satisfaction, and preference of care at the end of the trial. Data collection will be done by questionnaires and extractions from electronic medical records. DISCUSSION: The results of this study will provide evidence, which has been scarce to date, on prominent general practitioner involvement in care for colon cancer patients after initial treatment. Also, it evaluates the efficacy of an eHealth application to enhance patient empowerment. DUTCH TRIAL REGISTER: NTR4860 (registered on 2 October 2014).

Indexed as

Clinical ProtocolsPrecision MedicineQuality of LifeColonic NeoplasmsHumansQuality of Health Care

Identifiers

PMID26112050
PMCPMC4499213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.